8 January 2019 - A simple reform to improve outcomes and control costs.
In the U.S., medications are priced and sold by the pill, capsule or fluid ounce. A better approach would be to charge different prices for a medicine based on the disease for which it is prescribed.
While the current drug-purchasing system is too complex to reform overnight, there is a simple change that could improve health outcomes and control spending: disease-specific rebates.